Updated:
Panos Partners
Scott established the firm, originally Bridgepoint Partners, in 2005 following the sale of his second technology company.
Panos Partners
Scott established the firm, originally Bridgepoint Partners, in 2005 following the sale of his second technology company. He then managed a portfolio spanning healthcare, software and event-technology businesses before reconstituting the firm as Panos Partners in November 2016. Brian Hart, a former Cheniere Energy internal private equity executive, joined as Managing Partner, adding energy-sector financial discipline to a team that also includes Operating Partner Kurt Lentz, who previously executed deals at New State Capital Partners, Atlantic Street Capital and Sun Capital Partners. Panos writes equity checks into founder-owned businesses with EBITDA above $5 million and established revenue models. Its platform strategy is most visible in Memorial MRI & Diagnostic, a Texas-based diagnostic imaging and pain management provider expanded from ten locations in October 2019 to seventeen across Dallas-Fort Worth and Houston following the acquisition of Prime Imaging Partners—a deal nominated for the 2022 DCEO M&A Awards in the $50M–$250M transaction category. In event services, the firm participated alongside New State Capital Partners in The Expo Group, demonstrating a willingness to co-invest rather than always lead. Geographically, the firm concentrates on the United States, with a disclosed focus on Texas markets for its healthcare roll-ups. Headcount and total committed capital remain undisclosed. The senior trio of Scott, Hart and Lentz shares investment committee responsibilities, with Lentz providing the operational playbook gleaned across four prior private equity platforms. Panos was named a finalist for the 2022 DCEO M&A Awards for its Memorial MRI add-on, signaling regional recognition for deal execution. Adjacent vehicles or philanthropic structures are not publicly disclosed. Panos operates with a structure common among lower-middle-market shops but unusual in its dual-sector concentration: it runs parallel buy-and-build platforms in diagnostic imaging and event services, two industries rarely combined under one firm. This concentrated model means the firm actively competes in deal processes where sellers weigh a narrow sector reputation against broader multi-asset-class buyers.
General information
Firm type
Private Equity
Year founded
2005
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Dallas, TX, United States
Principals
Bryan A. Scott
Managing Partner and Founder
Brian Hart
Managing Partner
Kurt Lentz
Operating Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Panos Partners?
Managing Partners Bryan A. Scott and Brian Hart lead investment decisions, with Operating Partner Kurt Lentz driving operational strategy post-acquisition. Scott founded the firm in 2005 and reconstituted it under the Panos name in 2016; Hart joined from Cheniere Energy's internal private equity team. Lentz manages portfolio company performance, drawing on his prior roles at New State Capital Partners, Atlantic Street Capital and Sun Capital Partners.
How does Panos Partners source proprietary deal flow?
The firm targets founder-owned businesses generating $30 million to $200 million in annual revenue, sourced through relationship-based outreach to owners seeking a liquidity event. Its concentrated sector focus on healthcare services and business services allows the partners to develop a narrow network of repeatable referrals from operators, advisors and industry contacts rather than broad auction processes.
Is Panos Partners structured as a single family office or a private equity fund?
Panos Partners is a private equity firm, not a family office. It raises external capital and deploys it into middle-market platform companies and add-on acquisitions. The website does not disclose a committed-fund structure publicly, but the firm's transaction history reflects a sponsor model rather than a proprietary family capital vehicle.
Does Panos Partners participate in fund commitments or only direct deals?
The firm executes direct control investments and add-on acquisitions, most notably building its Memorial MRI & Diagnostic platform through multiple acquisitions. It has also co-invested alongside New State Capital Partners in The Expo Group, confirming a willingness to join other sponsors' deals when the opportunity fits its sector expertise.
What investment stages does Panos Partners target?
Panos invests in mature, cash-flow-positive companies with EBITDA exceeding $5 million. It pursues buyout and growth-stage transactions, focusing on founder liquidity events rather than early-stage or venture deals. The firm then drives expansion through organic growth and strategic add-on acquisitions, as executed in the Texas diagnostic imaging market.
What is Panos Partners' known posture on co-investments alongside external GPs?
Panos co-invested with Backcast Partners in a growth capital round for Memorial MRI & Diagnostic in October 2019 and again in September 2021 for a strategic add-on acquisition. It also participated in New State Capital Partners' investment in The Expo Group, demonstrating a flexible approach to partnering with other private equity firms.
Which sectors does Panos Partners avoid?
The firm explicitly focuses on healthcare services and business services. Its disclosed portfolio covers diagnostic imaging, healthcare services, event services and broader business services. There is no public indication of activity in technology, industrials, energy transition, real estate or consumer products outside of these two verticals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: